1
|
Redmond A, Zhang F, Cheng W, Gollapudi BB. In vitro and in vivo assessments of the genotoxic potential of 3-chloroallyl alcohol. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 2023; 64:26-38. [PMID: 36314072 PMCID: PMC10099214 DOI: 10.1002/em.22515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 10/06/2022] [Accepted: 10/20/2022] [Indexed: 06/16/2023]
Abstract
3-Chloroallyl alcohol (3-CAA) can be found in the environment following the application of plant protection products. 3-CAA is formed in groundwater following the injection of 1,3-dichloropropene, a fumigant used to control nematodes. 3-CAA is also formed, in leafy crops, as a glycoside conjugate following application of the herbicide, clethodim. Human exposure may occur from groundwater used as drinking water or through dietary consumption. To characterize 3-CAA's potential to cause genotoxicity in mammals, in vitro and in vivo studies were conducted. 3-CAA was negative in an Ames test and positive in a mouse lymphoma forward mutation assay. 3-CAA was negative in an acute in vivo CD-1 mouse bone marrow micronucleus assay when administered up to a dose level of 125 mg/kg/day for two consecutive days. In a combined gene mutation assay and erythrocyte micronucleus assay, using transgenic Big Blue® Fischer 344 rats, 3-CAA was administered via drinking water at targeted dose levels of 0, 10, 30, and 100 mg/kg/day for 29 days. Peripheral blood samples, collected at the end of treatment, were analyzed for micronucleus induction in reticulocytes using flow cytometry. Liver and bone marrow samples, collected 2 days after the termination of the treatment, were analyzed for the induction of mutations at the cII locus. 3-CAA did not induce an increase in mutant frequency or micronuclei under the experimental conditions. In conclusion, the mutagenic response observed in the in vitro mouse lymphoma assay is not confirmed in the whole animal. 3-CAA is not considered to pose a mutagenic risk.
Collapse
Affiliation(s)
- Aisling Redmond
- Science & Data Generation DepartmentUPL Europe Ltd.WarringtonUK
| | - Fagen Zhang
- Toxicology and Environmental Research and ConsultingThe Dow Chemical CompanyMidlandMichiganUSA
| | - WanYun Cheng
- Science & Data Generation DepartmentUPL LimitedDurhamUSA
| | | |
Collapse
|
2
|
Bartels MJ, Hackett MJ, Himmelstein MW, Green JW, Walker C, Terry C, Rasoulpour R, Challender M, Yan ZJ. Metabolic Basis for Nonlinearity in 1,3-Dichloropropene Toxicokinetics and Use in Setting a Kinetically-derived Maximum Inhalation Exposure Concentration in Mice. Toxicol Sci 2021; 174:16-24. [PMID: 31808915 DOI: 10.1093/toxsci/kfz241] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
1,3-Dichloropropene (1,3-D) showed a statistically increased incidence of bronchioloalveolar adenomas in male B6C3F1 mice at 60 ppm air concentration during previous chronic inhalation testing. No tumors were observed in female mice, nor in either sex of F344 rats up to 60 ppm, the highest dose tested. Therefore, to understand if lung tumors observed in high dose male mice are due to saturation of metabolic clearance, the linearity of 1,3-D concentrations in mouse blood was investigated on day 15 of repeated nose-only inhalation exposure to 0, 10, 20, 40, 60, 90, and 120 ppm (6 h/d, 7 d/week). Additional groups were included at 20, 60, and 120 ppm for blood collection at 1.5 and 3 h of exposure and up to 25 or 40 min post-exposure to determine area-under-the-curve. The data provide multiple lines of evidence that systemic exposures to 1,3-D in the mouse become nonlinear at inhalation exposure levels of 30 ppm or above. A reduction in minute volume occurred at the highest exposure concentration. The glutathione (GSH)-dependent metabolism of 1,3-D results in significant depletion of GSH at repeated exposure levels of 30 ppm and above. This loss of GSH results in decreased metabolic clearance of this test material, with a concomitant increase of the 1,3-D isomers in circulating blood at exposure concentrations ≥30 ppm. Shifts in the ratio of cis- and trans-1,3-D also support nonlinear toxicokinetics well below 60 ppm. Based on this data, a kinetically derived maximum dose for 1,3-D in mice for repeated exposures should be at or below 30 ppm. These results support non-relevance of 1,3-D-induced benign pulmonary tumorigenicity in mice for human health risk assessment.
Collapse
Affiliation(s)
| | - Michael J Hackett
- Battelle Memorial Institute, Clinical and Nonclinical Research, West Jefferson, Ohio
| | | | - John W Green
- Corteva AgriscienceTM, Research and Development, Newark, Delaware
| | - Carl Walker
- Corteva AgriscienceTM, Data Management and Statistics, Johnston, Iowa
| | - Claire Terry
- Corteva AgriscienceTM, Research and Development, Indianapolis, Indiana
| | - Reza Rasoulpour
- Corteva AgriscienceTM, Research and Development, Indianapolis, Indiana
| | - Mary Challender
- Corteva AgriscienceTM, Regulatory and Stewardship, Johnston, Iowa
| | - Zhongyu June Yan
- Corteva AgriscienceTM, Research and Development, Indianapolis, Indiana
| |
Collapse
|
3
|
Yan ZJ, Bartels M, Gollapudi B, Driver J, Himmelstein M, Gehen S, Juberg D, van Wesenbeeck I, Terry C, Rasoulpour R. Weight of evidence analysis of the tumorigenic potential of 1,3-dichloropropene supports a threshold-based risk assessment. Crit Rev Toxicol 2021; 50:836-860. [PMID: 33528302 DOI: 10.1080/10408444.2020.1845119] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
1,3-Dichloropropene (1,3-D; CAS #542-75-6) is a fumigant used for preplant treatment of soil to control parasitic nematodes and manage soil borne diseases for numerous fruit, vegetable, field and tree and vine crops across diverse global agricultural areas. In the USA, 1,3-D has historically been classified by the U.S. EPA as likely to be carcinogenic to humans via both oral and inhalation routes. This classification for the oral route was primarily based upon increases in multiple tumor types observed in National Toxicology Program (NTP) cancer bioassays in rats and mice, while the classification for the inhalation route was based upon increased benign bronchioloalveolar adenomas in a mouse study conducted by The Dow Chemical Company. Based on U.S. EPA standard risk assessment methodologies, a low-dose linear extrapolation approach has been used to estimate risks to humans. Furthermore, genotoxicity associated with 1,3-D was historically considered a potential mode of action (MOA) for its tumorigenicity. New information is available and additional studies have been conducted that reveal a different picture of the tumorigenic potential of 1,3-D. These data and information include: (1) initial cancer studies by the NTP were conducted on an antiquated form of 1,3-D which contained a known mutagen/carcinogen, epichlorohydrin, as a stabilizer while current 1,3-D fumigants use epoxidized soybean oil (ESO) as the stabilizer; (2) results from two additional oral rodent cancer bioassays conducted on the modern form of 1,3-D became available and these two studies reveal a lack of carcinogenicity; (3) a newly conducted Big Blue study in F344 rats via the oral route further confirms that 1,3-D is not an in vivo genotoxicant; and (4) a newly conducted repeat dose inhalation toxicokinetic (TK) study shows that linear dose proportionality is observed below 30 ppm, which demonstrates the non-relevance of 60 ppm 1,3-D-induced benign lung tumors in mice for human health assessment. This weight of evidence review is organized as follows: (a) the TK of 1,3-D are presented because of relevant considerations when evaluating test doses/concentrations and reported findings of tumorigenicity; (b) the genotoxicity profile of 1,3-D is presented, including a contemporary study in order to put a possible genotoxicity MOA into perspective; (c) the six available bioassays are reviewed followed by (d) scientifically supported points of departure (PODs) and evaluation of human exposure for use in risk assessment. Through this assessment, all available data support the conclusion that 1,3-D is not a tumorigen at doses below 12.5 mg/kg bw/day via the oral route or at doses below 30 ppm via the inhalation route. These findings and clearly identified PODs show that a linear low dose extrapolation approach is not appropriate and a threshold-based risk assessment for 1,3-D is human health protective. Finally, in 2019, the Cancer Assessment Review Committee (CARC) reevaluated the carcinogenic potential of 1,3-D. In accordance with the EPA's Final Guidelines for Carcinogen Risk Assessment, the CARC classified 1,3-D (Telone) as "Suggestive Evidence of Carcinogenic Potential based on the presence of liver tumors by the oral route in male rats only." Given this finding, EPA stated that "quantification of human cancer risk is not required. The CARC recommends using a non-linear approach (i.e. reference dose (RfD)) that will adequately account for all chronic toxicity including carcinogenicity, that could result from exposure to 1,3-dichloropropene."
Collapse
Affiliation(s)
| | | | | | | | | | - Sean Gehen
- Corteva Agriscience, Indianapolis, IN, USA
| | - Daland Juberg
- Juberg Toxicology Consulting LLC, Indianapolis, IN, USA
| | | | | | | |
Collapse
|
4
|
Klaunig JE, Gehen SC, Wang Z, Klein PJ, Billington R. Mechanism of 1,3-dichloropropene-induced rat liver carcinogenesis. Toxicol Sci 2014; 143:6-15. [PMID: 25354764 DOI: 10.1093/toxsci/kfu221] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
1,3-Dichloropropene (1,3-D) is a soil fumigant used primarily for preplanting control of parasitic nematodes. In a previous chronic dietary exposure study, 1,3-D induced an increased incidence of hepatocellular adenomas in male rats at a dose of 25 mg/kg/day. Although the mechanism for tumor induction in the rat liver by 1,3-D has not been specifically elucidated, available data suggested that the observed liver tumorigenesis was through a nongenotoxic mode of action at the tumor promotion stage. Fischer 344 rats containing preneoplastic lesions were treated (via gavage) with 25 mg/kg/day 1,3-D or 80 mg/kg/day phenobarbital (PB) for 30 days and 60 days, or for 30 days followed by a 30-day recovery period (no compound exposure). Following treatment, placental form glutathione S-transferase (GSTP) positive and GSTP-negative liver focal lesions were quantitated as to size and number. 1,3-D treatment had no effect on GSTP-positive foci number or relative size but significantly increased the number, labeling index, and relative size of GSTP-negative focal lesions (identified by H and E staining) after 30 and 60 days of treatment. Following the 30-day recovery period, the number, labeling index, and relative size of the GSTP-negative lesions in 1,3-D-treated animals returned to control levels. As expected, PB treatment produced an increase in number and relative size of the GSTP-positive lesions. The results of this study are consistent with 1,3-D inducing liver carcinogenesis through a nongenotoxic mode of action by functioning as a tumor promoter specifically through induction of a non-GSTP staining focal hepatocyte population.
Collapse
Affiliation(s)
- James E Klaunig
- *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268 *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268
| | - Sean C Gehen
- *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268
| | - Zemin Wang
- *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268 *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268
| | - Patrick J Klein
- *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268
| | - Richard Billington
- *Department of Environmental Health, Indiana University, Bloomington, Indiana 47405, Department of Pharmacology/Toxicology, Indiana University, Indianapolis, Indiana 46202, and Dow Agro Sciences, Indianapolis, Indiana 46268
| |
Collapse
|